healthcare professional for medical advice
case symptom
disable joint pain
red skin lesion
month
sulfonylurea
necrotize pancreatitis
ulcer
month after discontinuation
substantial reduction in prior activity level
case of severe arthralgia
severe joint pain
runny nose
n rrb
rash
headacheuncommon
cold sweat
sore throat
lip
fda
return
body ache
weakness
october
vomit
seizure
foot
loss of consciousness
nausea
swell of the eyelid
health care professional
skin rash
hive like swell on the face
hive
hepatic enzyme elevation
slurred speech
involve use of a different dpp
dizziness
side
cutaneous vasculitis
eyelid
constipation
abdominal pain
vildagliptin
back
worsen renal function
angioedema
depression
more dipeptidyl peptidase
worsen
nightmare
sitagliptin
acute renal failure
greatest number of case
medicine
alogliptin
incidence of acute pancreatitis
body
loosening of the skin
peel
leg
confusion
interstitial lung disease
cough
blister
muscle ache
baseline level of renal insufficiency
hypoglycemia
nasopharyngitis
causative agent
tongue
placebo
extremity pain
combination with insulin
blur vision
sex organ
radiate
positive rechallenge
urticaria
active control
use
eye
unusual tiredness
sneeze
puffiness
loss of voice
pain in the stomach
headache
loss of appetite
pharyngitis
sore
linagliptin
steven johnson syndrome
chill
case
medical attention
anxiety
purple center
myalgia
difficulty with breathing
n
inhibitor
discontinuation
december
upper respiratory infection
hypertension
anaphylaxis
saxagliptin
throat
cool pale skin
acute pancreatitis
diarrhea
exfoliative skin condition
require dialysis
fever
pain
itch
abdomen
hand
white spot in the mouth
osteoarthritis
disable
upper respiratory tract infection
stomach pain
ear congestion
fast heartbeat
increase hunger
arthralgia
face
shakiness
redness of the skin
welt